Klotho Neurosciences, Inc.
KLTO
$0.7488
$0.068810.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.96M | 6.71M | 5.79M | 4.05M | 1.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.20M | 6.71M | 5.79M | 4.05M | 1.30M |
| Operating Income | -8.20M | -6.71M | -5.79M | -4.05M | -1.30M |
| Income Before Tax | -11.35M | -7.71M | -6.15M | -4.21M | -1.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.35 | -7.71 | -6.15 | -4.21 | -1.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.35M | -7.71M | -6.15M | -4.21M | -1.39M |
| EBIT | -8.20M | -6.71M | -5.79M | -4.05M | -1.30M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.46 | -0.36 | -0.33 | -0.26 | -0.09 |
| Normalized Basic EPS | -0.28 | -0.23 | -0.20 | -0.16 | -0.06 |
| EPS Diluted | -0.46 | -0.37 | -0.33 | -0.26 | -0.09 |
| Normalized Diluted EPS | -0.28 | -0.23 | -0.20 | -0.16 | -0.06 |
| Average Basic Shares Outstanding | 105.39M | 87.11M | 74.72M | 62.63M | 61.07M |
| Average Diluted Shares Outstanding | 105.39M | 87.11M | 74.72M | 62.63M | 61.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |